ethoxyresorufin has been researched along with 4-hydroxyestradiol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedberg, T; Li, DN; Pritchard, MP; Seidel, A; Wolf, CR | 1 |
| Amagai, T; Kuruto, R; Ohura, T; Sakakibara, H; Shimoi, K; Takemura, H; Uchiyama, H | 1 |
2 other study(ies) available for ethoxyresorufin and 4-hydroxyestradiol
| Article | Year |
|---|---|
Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Base Sequence; Carcinogens; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Dihydroxydihydrobenzopyrenes; DNA Primers; DNA, Complementary; Estradiol; Estrogens, Catechol; Ethanolamines; Humans; Hydroxylation; Kinetics; Mutagenesis, Site-Directed; Oxazines; Polymorphism, Genetic | 2000 |
A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
Topics: 2-Methoxyestradiol; Aryl Hydrocarbon Hydroxylases; Biocatalysis; Breast Neoplasms; Carcinogens; Catechol O-Methyltransferase; Cell Line, Tumor; Chemoprevention; Culture Media, Conditioned; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytosol; Enzyme Inhibitors; Estradiol; Estrogens, Catechol; Female; Flavones; Flavonoids; Gene Expression; Glucuronidase; Humans; Hydroxylation; Kinetics; Methylation; Oxazines; Recombinant Proteins; Sulfatases | 2010 |